Use UniProt O15264 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL2094115 Target Snapshot
MAP kinase p38 · PROTEIN FAMILY · Homo sapiens
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Protein identity stays anchored to UniProt O15264. Use UniProt O15264 as the stable identity anchor, then attach disease evidence before program review.
Mitogen-activated protein kinase 13
Review this target as MAP kinase p38, mapped to UniProt O15264. ChEMBL maps the protein component as Mitogen-activated protein kinase 13. Sequence length is 365 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats MAP kinase p38 as ChEMBL target CHEMBL2094115, mapped to UniProt O15264. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether MAP kinase p38 is the right protein anchor across sources, using UniProt O15264 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | MAP kinase p38 |
| Target Type | PROTEIN FAMILY |
| Organism | Homo sapiens |
| UniProt | O15264 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Mitogen-activated protein kinase 13 |
| UniProt Accession | O15264 |
| Component Type | Protein |
| Sequence Length | 365 aa |
Mitogen-activated protein kinase 13
How to read this target
Review this target as MAP kinase p38, mapped to UniProt O15264. ChEMBL maps the protein component as Mitogen-activated protein kinase 13. Sequence length is 365 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL194813 | 10.33 | Ki | 0.047 | Preclinical |
| CHEMBL363643 | 10.3 | Ki | 0.05 | Preclinical |
| CHEMBL196741 | 10.24 | Ki | 0.057 | Preclinical |
| CHEMBL197206 | 10.24 | Ki | 0.057 | Preclinical |
| CHEMBL103667 | 10.01 | Kd | 0.097 | Clinical |
| CHEMBL318810 | 10.0 | Kd | 0.1 | Preclinical |
| CHEMBL305178 | 9.96 | IC50 | 0.11 | Preclinical |
| CHEMBL195532 | 9.82 | Ki | 0.15 | Preclinical |
| CHEMBL545353 | 9.82 | IC50 | 0.15 | Preclinical |
| CHEMBL197351 | 9.8 | Ki | 0.16 | Preclinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
Binding — 367 assays, 444 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 198 | 27 | 7.0 |
| protein format | 125 | 319 | 6.9 |
| assay format | 38 | 94 | 6.9 |
| tissue-based format | 4 | 4 | 8.5 |
| mitochondrion format | 2 | 0 | — |
Functional — 53 assays, 319 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 23 | 152 | 7.0 |
| cell-based format | 17 | 115 | 6.4 |
| tissue-based format | 13 | 52 | 6.2 |
ADME — 1 assays, 6 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| protein format | 1 | 6 | 6.9 |